Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

PRP is an effective and safe treatment for alopecia areata.

PRP may help improve ovarian function, but more research is needed for consistent results.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Radiation treatment causes skin fibrosis by increasing certain fibroblast subpopulations, but using a c-Jun inhibitor or fat grafting can reduce this effect.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

PRP treatment lacks strong evidence for routine use due to poor study quality.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

More research and collaboration are needed to effectively use PRP, stem cells, and exosomes in medicine.

Pulse electric fields can control the release of growth factors and serotonin from platelet-rich plasma, offering a tailored approach to wound healing.

JAK inhibitors offer new hope for treating severe alopecia areata.

JAK inhibitors are effective for long-term management of alopecia areata.

Pityriasis rubra pilaris is a rare skin disorder with reddish-orange patches and thickened skin, needing better treatment understanding.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Platelet-rich plasma (PRP) is effective and safe for improving skin appearance.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Injecting Platelet-Rich Plasma reduces leakage risk in colorectal surgery.

Trazodone and Chlorpromazine might help treat sexual dysfunction from finasteride and SSRIs.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.